Nrf2 deficiency aggravates PM2.5-induced cardiomyopathy by enhancing oxidative stress, fibrosis and inflammation via RIPK3-regulated mitochondrial disorder

Chenxu Ge,Linfeng Hu,Deshuai Lou,Qiang Li,Jing Feng,Yekuan Wu,Jun Tan,Minxuan Xu
DOI: https://doi.org/10.18632/aging.102906
2020-03-17
Aging
Abstract:PM<sub>2.5</sub> is a well-known air pollutant threatening public health, and long-term exposure to PM<sub>2.5</sub> increases the risk of cardiovascular diseases. Nrf2 plays a pivotal role in the amelioration of PM<sub>2.5</sub>-induced lung injury. However, if Nrf2 is involved in PM<sub>2.5</sub>-induced heart injury, and the underlying molecular mechanisms have not been explored. In this study, wild type (Nrf2<sup>+/+</sup>) and Nrf2 knockout (Nrf2<sup>-/-</sup>) mice were exposed to PM<sub>2.5</sub> for 6 months. After PM<sub>2.5</sub> exposure, Nrf2<sup>-/-</sup> mice developed severe physiological changes, lung injury and cardiac dysfunction. In the PM<sub>2.5</sub>-exposed hearts, Nrf2 deficiency caused significant collagen accumulation through promoting the expression of fibrosis-associated signals. Additionally, Nrf2<sup>-/-</sup> mice exhibited greater oxidative stress in cardiac tissues after PM<sub>2.5</sub> exposure. Furthermore, PM<sub>2.5</sub>-induced inflammation in heart samples were accelerated in Nrf2<sup>-/-</sup> mice through promoting inhibitor of α/nuclear factor κB (IκBα/NF-κB) signaling pathways. We also found that Nrf2<sup>-/-</sup> aggravated autophagy initiation and glucose metabolism disorder in hearts of mice with PM<sub>2.5</sub> challenge. Cardiac receptor-interacting protein kinase 3 (RIPK3) expression triggered by PM<sub>2.5</sub> was further enhanced in mice with the loss of Nrf2. Collectively, these results suggested that strategies for enhancing Nrf2 could be used to treat PM<sub>2.5</sub>-induced cardiovascular diseases.
English Else
What problem does this paper attempt to address?